Cerba Research today announced听it was听awarded a five-year contract听for Clinical Central Laboratory Services听from听the听National Institute of Allergy and Infectious听Diseases听(NIAID),听part of the听U.S.听National Institutes of Health (NIH).
NIAID conducts and supports basic and applied research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases.听Findings from this research are vital to听NIAID鈥檚听efforts to听advance听vaccines, drugs, and diagnostic tools to better diagnose, prevent, and treat infectious diseases. Cerba Research will provide听clinical laboratory screening and safety testing听for听NIAID-supported clinical trials within the infectious disease area.听听
鈥淲e are听pleased to be recognised for our depth and breadth of central and speciality lab solutions across the globe听to support听NIAID.听Through our听innovative听mindset,听courageous听people, and our work in听vaccines and听treatments in the field of听infectious听diseases, we understand the importance in bringing these to听people.听Hence, we are committed to supporting the听NIAID鈥檚听clinical research听initiatives听to improve health,鈥澨齭aid Mario Papillon,听chief executive officer, Cerba Research.